(Q43637235)

25 November 2017

title

Hormonal erectile dysfunction. Evaluation and management (English)

1 reference

25 November 2017

Morales A

1

1 reference

25 November 2017

Heaton JP

series ordinal

2

1 reference

25 November 2017

language of work or name

1 reference

1 May 2001

1 reference

Urologic Clinics of North America

25 November 2017

published in

1 reference

25 November 2017

volume

28

1 reference

25 November 2017

issue

2

1 reference

25 November 2017

page(s)

279-288

1 reference

An assessment of the clinical relevance of serum testosterone level determination in the evaluation of men with low sexual drive

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Androgens in men--uses and abuses

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Androgen therapy in the aging male: assessing the effect on heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Changes in erectile responsiveness during androgen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Androgens: risks and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Psychoendocrine sequelae of chronic testosterone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Patients with primary hypothyroidism presenting as prolactinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Possible hypothalamic impotence. Male counterpart to hypothalamic amenorrhea?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Treatment of Isolated Hypogonadotropic Hypogonadism Effect on Bone Mineral Density and Bone Turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

An analysis of testosterone implants for androgen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

A therapeutic taxonomy of treatments for erectile dysfunction: an evolutionary imperative

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Profound hypogonadism has significant negative effects on calcium balance in males: a calcium kinetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Medical therapies for erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Selective Androgen Receptor Modulators (SARMs): A Novel Approach to Androgen Therapy for the New Millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Endocrine dysfunction in impotence: incidence, significance and cost-effective screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

The association of hypotestosteronemia with coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Kallmann's syndrome: is it always for life?

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Replacing testosterone in men

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Obstructive sleep apnea syndrome induced by testosterone administration

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Comparison of the kinetics of injectable testosterone in eugonadal and hypogonadal men

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Age-associated testosterone decline in men: clinical issues for psychiatry.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Testosterone replacement therapy in older adult men.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Uses and abuses of the male sex hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Beneficial effects of testosterone undecanoate on the lipoprotein profiles in healthy elderly men. A placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

The Apparent Free Testosterone Concentration, An Index of Androgenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

A critical evaluation of simple methods for the estimation of free testosterone in serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Clinical review 24: Androgens in the aging male

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Psychosexual effects of three doses of testosterone cycling in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970138-5

7 January 2021

10.1016/S0094-0143(05)70138-5

Identifiers

DOI

1 reference

25 November 2017

1 reference